Latest update

Our Latest Update

Explore the latest stories, global perspectives, and research updates shaping the future of health at Togontech.

  • News

    Togontech Launches Its New Brand Identity and Website

    We’re pleased to introduce Togontech’s new brand identity and website, a refreshed digital presence that reflects our mission, our science, and our vision for the future. This project was brought to life through the collaboration of a talented team. Special thanks to Marco Grimaldi for the design direction, Oriana Gaeta for her creative contribution, Patrick Heintzmann for the development, and Klaus Dyba for the portrait photography. We invite you to explore the new Togontech website.

    Visit Link
  • PRESS RELEASE

    HIV Antibody Opens New Approaches for Vaccine Development and Combination Therapies

    Togontech supports the preclinical development of HIV antibody 007, advancing new possibilities for combination therapies and vaccine development. Source: University of Cologne

    Read Original Article
  • Publication

    Broadly Neutralizing Antibody 007 Published in Nature Immunology

    Our new Nature Immunology publication introduces 007, a novel broadly neutralizing antibody targeting the HIV-1 V3 glycan site. The findings open new opportunities for antibody-based therapies and vaccine design.

    Visit Link
  • News

    Welcoming Ivanna Marchesini to Our Scientific Team

    We’re happy to welcome Ivanna Marchesini to Togontech’s Team. Ivanna joins us to support our translational research and laboratory activities, bringing scientific curiosity, precision, and a collaborative spirit.

    Visit Link
  • Publication

    Discovery of Broadly Neutralizing Antibody 04_A06 Published in Nature Immunology

    Nature Immunology published our discovery of broadly neutralizing HIV-1 antibody 04_A06, one of the broadest and most potent CD4 binding site antibodies identified to date.

    Visit Link
  • News

    Collaborating with the V3ECTORY HCV Vaccine Programme

    Togontech will collaborate with researchers at TWINCORE on the V3ECTORY HCV Vaccine Programme, bringing its expertise to support next-generation HCV vaccine development.

    Visit Link
  • News

    Togontech Opens Its First Laboratory

    Located in the vibrant city of Cologne, Germany, this new establishment is set to enhance the company's research capabilities and foster innovation in various technological fields.

  • News

    Togontech Opens Its First Office in InnoDom Cologne

    Our first office in InnoDom Cologne, marks an important milestone in Togontech's growth, providing the foundation for expanding our scientific and business activities.

    Visit Link

Shape the Future of Human Health

PartnershipsDevelopmentOpportunities

Whether you are interested in our single-cell discovery platform or exploring co-development opportunities, our team is ready to provide the technical expertise and strategic agility your pipeline requires.

Partner with us